Navigation Links
MDA Collaborates with AVI BioPharma on First Phase 2 Placebo-Controlled Clinical Trial of Exon-51 Skipping Drug as Potential Therapy for Duchenne Muscular Dystrophy
Date:8/15/2011

TUCSON, Ariz., Aug. 15, 2011 /PRNewswire-USNewswire/ -- More than a decade of targeted Muscular Dystrophy Association-funded research, made possible as a result of generous public support of the MDA Labor Day Telethon and thousands of grass-roots special events, has today culminated in MDA providing financial assistance for the start of the first Phase 2 placebo-controlled, multiple dose efficacy, safety, tolerability and pharmacokinetics clinical trial of an exon-51 skipping drug, eteplirsen, as a potential therapy for Duchenne muscular dystrophy (DMD).

The first three of 12 DMD boys participating in the AVI BioPharma clinical trial at Nationwide Children's Hospital in Columbus, Ohio today received the first of 24 weekly doses of eteplirsen or a placebo by intravenous infusion (i.v.).  Four more participants had muscle biopsies vital to measuring the presence of the essential muscle protein dystrophin both before and after treatments.  The seven boys traveling in for the study launch are from Calif., Ill., Fla., Wis., Va. and Mo.

"This is an important day for families fighting muscular dystrophy," said R. Rodney Howell, M.D., Chairman of the MDA Board of Directors. "AVI BioPharma already completed a 19-patient clinical trial in the United Kingdom confirming the potential of eteplirsen to be a safe and effective disease-modifying drug for DMD (The Lancet, July 25, 2011).  Now, a team led by Dr. Jerry Mendell is receiving funding from MDA to help initiate this randomized, double-blind, placebo-controlled 12-patient trial needed to further test safety, efficacy and optimal dosing."

"Twenty-five years ago, MDA-funded investigators identified the dystrophin gene that, when mutated (or defective) causes Duchenne muscular dystrophy as well as the somewhat milder Becker muscular dystrophy (BMD)," explained Mendell, Curran-Peters Chair of Pediatric Research at Nationwide Children's Hospital, and Professor of Pediatrics and Neurology at
'/>"/>

SOURCE Muscular Dystrophy Association
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. PharmaNet Collaborates With the Cancer Immunotherapy Trials Network
2. CoreLab Partners Collaborates at Worldwide Industry Conferences
3. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
4. Brainlab Collaborates With Toshiba Medical Systems on Integrated Surgical Suite
5. SIRO Clinpharm Collaborates with Mediscis, Broadens Early Phase Drug Development Expertise
6. GlaxoSmithKline Collaborates with National Cancer Institute to Make Large Body of Cancer Cell Genomic Data Available to All Cancer Researchers
7. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
8. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
9. Comparative Study Confirms Enox Biopharmas Antimicrobial Superiority to Commercially Available Silver Coated Catheters
10. Biopharma Leaders Discuss Pharmas Future at Pharmaceutical Strategic Alliances in New York
11. Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Kinex Pharmaceuticals announced today that the first ... Cancer Institute. KX2-361 (KX02), a dual src/pre-tubulin ... potent inhibitory activity against a broad panel of brain ... Temozolomide (T98G), the most widely used chemotherapy for the ... mouse model, KX2-361 consistently clears brain tumors after 4 ...
(Date:12/24/2014)... N.J. and FARMINGTON, Conn. ... Technologies, Inc. (NYSE MKT: PTN), a biopharmaceutical company ... of diseases with significant unmet medical need and ... on a private placement of 2,050,000 shares of ... purchase 24,949,325 shares of its common stock.  Funds ...
(Date:12/24/2014)... Dec. 23, 2014 ResMed (NYSE: RMD ... action against Chinese medical device manufacturer BMC Medical Co., Ltd. ... that BMC,s masks listed below infringe ResMed,s patents, and entered ... masks in the United States : ... mask , Willow nasal pillows mask , iVolve ...
Breaking Medicine Technology:Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 2Kinex Pharmaceuticals Announces First Patient Dosed with KX2-361 in a Phase 1 Clinical Study 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 2Palatin Completes $20 Million Equity and $10 Million Debt Financings 3Palatin Completes $20 Million Equity and $10 Million Debt Financings 4ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2
... , PHILADELPHIA, Pennsylvania, December 2 ... global specialty biopharmaceutical,company, announces that it has settled the ... to Teva of an,authorized generic version of ADDERALL XR. ... since April 1, 2009. Shire,s ability to supply,the product ...
... Dec. 2 Novavax, Inc. (Nasdaq: NVAX ) today ... two-stage pivotal Phase II study evaluating the safety and immunogenicity ... vaccine. Novavax is conducting this study in collaboration with ... in Mexico and potentially other countries. , In Stage A ...
Cached Medicine Technology:Shire and Teva Settle Litigation Concerning Supply of ADDERALL XR Authorized Generic 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 2NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 3NOVAVAX Reports Positive Clinical Results from Pivotal Study of H1N1 Influenza Vaccine in Mexico 4
(Date:12/25/2014)... December 25, 2014 Recently, BellasDress ... on all its wedding dresses. BellasDress has chosen their ... for gift choices for the holiday season. , ... pick suitable wedding gowns here at discount prices. The ... experience at its website. , “All our ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 When head lice ... themselves in a frenzy to get rid of it while ... families in Coral Gables now have the solution right in ... salon clinic location, Lice Troopers provides full spectrum head lice ... Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut Grove, ...
(Date:12/25/2014)... Dec. 25, 2014 (HealthDay News) -- The risk of ... holidays, so you need to be extra cautious, an ... we see a significant increase in patients coming in ... the Suffolk County Volunteer Firefighters Burn Center of Stony ... should be full of joy, but if not careful, ...
(Date:12/25/2014)... Dennis Thompson HealthDay ... Researchers could be closing in on a "fountain of youth" ... the health of older adults, a new study suggests. ... given a drug that targets a genetic signaling pathway linked ... Novartis report. The experimental medication, a version ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as ... coolest mobile applications on the iOS, Android, and Windows markets. ... conducted the app review and shared with viewers how this ... The old saying goes, “A picture says a thousand words.” ... describe a single image, because each picture holds a unique ...
Breaking Medicine News(10 mins):Health News:BellasDress.com’s Christmas Sale: Trendy Wedding Dresses With Big Discounts 2Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2
... HUNTSVILLE, Ala., April 15 Open Biosystems, ... science research,tools for drug discovery, today announced ... pools for multiplexed RNAi screens. This,novel offering ... and,the ability to rapidly screen through thousands ...
... Help Public Health Move Beyond Traditional Syndromic Surveillance ... ... Health Monitoring Systems (HMS), (http://www.hmsinc.com ), pioneering health data ... an online system featuring robust,new data and analytical tools ...
... and NEW YORK, NY Two global research organizations ... International AIDS Vaccine Initiative (IAVI), and the Center for ... to work together to address major biological questions that ... AIDS vaccine. , Solving the HIV vaccine puzzle ...
... minutes during their ... workday, ... Walking Day. The call to action is simple:,Americans should fit 30 minutes ... Release, go to:, http://www.prnewswire.com/mnr/aha/32529/ Studies reveal that American jobs have ...
... Raise Money for Cystic Fibrosis -, DUCK KEY, Fla., ... Sunrise/Sunset Tarpon Tournament hosted by Hawks Cay on Duck,Key in ... the,Cystic Fibrosis Foundation., Wade Boggs, a member of the ... for the event. Boggs is a former third baseman in,Major ...
... effective at preventing acute respiratory illness and making sure ... to research published in the April issue of IJCP, ... study of 87 patients with chronic obstructive pulmonary disease ... death - found that having the annual flu vaccine ...
Cached Medicine News:Health News:Open Biosystems Launches Decode RNAi Viral Screening Pools for Low-Cost Genome-Scale RNAi Screens 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 2Health News:Health Monitoring Systems Releases EpiCenter(TM) 3Health News:Health Monitoring Systems Releases EpiCenter(TM) 4Health News:Leading HIV researchers to collaborate on vaccine development 2Health News:Leading HIV researchers to collaborate on vaccine development 3Health News:Video: Start! Walking America: The American Heart Association's National Start! Walking Day Is April 16 2Health News:Video: Start! Walking America: The American Heart Association's National Start! Walking Day Is April 16 3Health News:Hawks Cay Hosts Redbone Sunrise/Sunset Tarpon Tournament 2Health News:Flu vaccines can reduce respiratory problems by up to 3/4 2Health News:Flu vaccines can reduce respiratory problems by up to 3/4 3
... Microbicide for professional degerming, pre-op and ... disinfectants combining quaternary and substituted phenolic ... of emollients and surfactants. Unprecedented efficacy ... tested in 30 seconds. Techni-Care represents ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... multi-purpose topical solution is for ... Prep Spray is labeled for ... of cross contamination. The controlled ... method to the final step ...
... and four ounce bottles are ... needs of procedural kit and ... has been custom molded to ... cap perfectly. This product has ...
Medicine Products: